Pre-ASCO中国临床肿瘤峰会美中抗癌协会(USCACA)世易医健(eChinaHealth)主办,百济神州(BeiGene)合办。全新上线的网络会议将为您涉猎更广更热门的议题并邀请更多嘉宾。

第一期网络会议主题“COVID-19疫情期间的肿瘤临床试验”,在COVID-19疫情期间,临床试验在全球范围内遭受影响。癌症患者无论在临床治疗或是临床试验上都受到严重影响。我们邀请了来自中美两国的临床肿瘤专家李进教授,周彩存教授,Howard (Skip) Burris 教授,Rebecca Heist教授和Bob Li 教授分享他们在COVID-19期间管理临床治疗和试验的经验。我们还邀请了郭彤博士讨论应用数字化工具减少病患和医生在临床试验期间的接触,保证临床试验的良好进展。

 

主 办 方

                                   

合办方

                                                             

时  间

5月9日周六(中国时间) 上午9点

5月8日周五(美国东部时间) 晚上9点

                                                                 5月8日周五(美国西部时间) 晚上6点

报 名 注 册

                                                                 会议开放免费注册,请扫描下方二维码报名

                                                                              

                                                                我们将于会议前以邮件形式发送给您参会邀请

                                                                   会    议    赞    助

此次Pre-ASCO中国临床肿瘤峰会系列网络会议的赞助将最大程度的提升您在行业的曝光度!欢迎咨询销售经理,收获丰富的权益回报。


                                                               ASCO中国会议微信群

每期网络会议结束,我们将在微信群内发布该场会议视频及后续精彩会议!不想错过更多ASCO中国会议精华演讲?就请加入我们!     

                            请扫描二维码加入,或添加会议经理入群!

                                           预   告

                          ASCO Direct™ China 网络会议

最及时01

世易医健获得ASCO官方授权在大中华区独家举办“2020 ASCO Direct™ China”系列中国会议,将ASCO会议发布的最新突破性进展浓缩为精华亮点,让中国肿瘤医生不出国门也能学习了解国际最前沿的研究进展。

最权威02

2020 ASCO Direct™ China网络会议将由我们的专家委员会选取2020年美国临床肿瘤学会年会(ASCO Annual Meeting)与ASCO胃肠道癌症专题会议(ASCO Gastrointestinal Cancers)、ASCO 泌尿生殖系统癌症专题会议(ASCO Genitourinary Cancers Symposium)和ASCO-SITC临床免疫肿瘤学专题会议(ASCO-SITC Clinical Immuno-Oncology Symposium)精华内容,按照系列主题,视频动态再现肿瘤领域最新研究与进程的精彩演讲!

最全面03

2020 ASCO Direct™ China网络会议将采用专题精华演讲+Q/A与解读环节形式,使您全方位理解会议内容!

全新上线的网络会议为您涉猎更权威更热门的议题并邀请大牌嘉宾参与交流,“ASCO中国会议微信群”欢迎您的加入!

美中抗癌协会

US Chinese Anti-Cancer Association

U.S. Chinese Anti-Cancer Association (USCACA) is a non-profit professional organization founded in 2009. With members from academia, industry and government, USCACA facilitates collaboration among cancer research and physicians in the United States and China. Our current focus is on expediting novel cancer drug development by fostering clinical trial networks, sharing best practices and knowledge of clinical trial, and providing education and training opportunities. USCACA collaborates with Chinese Anti-Cancer Association, Chinese Society for Clinical Oncology, and other professional associations. Our mandate is to improve cancer treatment through research, education, and collaboration.

世易医健

eChinaHealth

eChinaHealth is an integrated media for China healthcare and pharmaceutical segments. eChinaHealth services include digital platform and media, conferences and events, data and consulting, and social network and community.

eChinaHealth is exclusive China sale representation for ASCO Publications including “Journal of Clinical Oncology”, “Journal of Clinical Practice”, and “ASCO Post”, etc. eChinaHealth and ASCO plan to organize a series of ASCO Direct™ conference in China. The ASCO Direct™ program is an educational initiative that condenses highlights from ASCO Meeting into a 1-day China program, in an effort to provide Chinese doctors’ access to the most cutting-edge research discussed at ASCO meetings.

百济神州

BeiGene

BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. Our mission is to become a global leader in the discovery, development, and commercialization of innovative, molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.